Torres Joseph E, Nagpal Ameet S, Iya Alice, McGeary Donald, Srinivasan Malathy
UT Health San Antonio, Department of Anesthesiology.
Rehabilitation Medicine; Associate Professor, Psychiatry, UT Health San Antonio.
Curr Phys Med Rehabil Rep. 2020 Sep;8(3):229-239. doi: 10.1007/s40141-020-00265-5. Epub 2020 May 14.
I.To provide an overview of current interventional treatment options for women with chronic pelvic pain (CPP).
II.Accessibility of CT imaging, ultrasound, and fluoroscopy have assisted the development of novel interventional techniques. Similarly, neuromodulation techniques have improved with the development of novel stimulation patterns and device implants.
III.Numerous small-scale studies report high success rates with injection intervention therapies in CPP but there are limited well designed large-scale studies that demonstrate superiority of treatment. Female pelvic pain is difficult to diagnose due to the multifactorial etiology and the variable presentation causing delay in accurate diagnosis and lack of response to conventional medical and initial interventional therapies. Despite the shortfalls of current studies, collectively our understanding of chronic pain conditions and helpful injection interventions are improving. Undoubtedly the breadth of current research will provide a rich foundation for future large-scale well-designed studies involving multiple disciplines with more uniform methods and criteria to produce reliable and reproducible results.
I. 概述慢性盆腔疼痛（CPP）女性患者目前的介入治疗选择。
II. CT成像、超声和荧光镜检查的可及性推动了新型介入技术的发展。同样，随着新型刺激模式和设备植入技术的发展，神经调节技术也有所改进。
III. 众多小规模研究报告称，注射干预疗法治疗CPP的成功率很高，但设计良好的大规模研究有限，无法证明治疗的优越性。由于病因多因素且表现多样，女性盆腔疼痛难以诊断，导致准确诊断延迟，且对传统医学和初始介入治疗无反应。尽管目前的研究存在不足，但总体而言，我们对慢性疼痛状况和有效的注射干预的理解正在不断提高。毫无疑问，当前研究的广度将为未来涉及多学科、方法和标准更统一的大规模精心设计的研究提供丰富基础，以产生可靠且可重复的结果。
